Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 5.02
+0.24 (4.91%)
Sep 16, 2025, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 1.13 billion as of September 16, 2025. Its market cap has increased by 139.94% in one year.
Market Cap
1.13B
Enterprise Value
1.20B
Revenue
50.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.02
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 1.13B, a decrease of -32.12%. That is a compound annual growth rate of -4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.08B | 222.63% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | 11.53B | 63.96% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 93.75B |
| Sectra AB | 61.85B |
| Getinge AB | 57.69B |
| Camurus AB | 43.47B |
| Medicover AB | 39.86B |
| Asker Healthcare Group AB | 36.20B |
| BioArctic AB | 23.97B |
| AddLife AB | 22.86B |